Arentfox Schiff LLP
Arentfox Schiff LLP filed a Q4 report for Children's Healthcare of Atlanta on January 18, 2026, reporting $50,000 in lobbying income.
Lobbying for Children's Healthcare of Atlanta · Pediatric health care system
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally Pediatric Student Loan Repayment program Enhanced premium tax credit
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), regarding Department of Health and Human Services funding